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A b s t r a c t 
The study investigates dietary intakes of energy and 
selected nutrients of a sample haemodialysis population in the 
Hunter region, N.S.W. and compares to recommended standard 
intakes for a haemodialysis population. The sample consisted of 
37 subjects in total, with representative proportions from each of 
the three dialysis categories, namely centre, home and limited 
care patients. Patients were asked to keep a three day Food and 
Drink Diary, covering two non-dialysis days and one dialysis day. 
A self-administered questionnaire was designed to ensure a more 
accurate computer data entry process. Diaries were analysed on 
the Diet 1 (NutTab 92) Computer Package. 
StatView 512 Computer Package was used to analyse the 
statistical significance between the actual and recommended 
intakes of nutrients and within the three dialysis categories to 
determine whether the sample adhered to the recommendations 
and if there were any differences between groups. 
Protein, phosphate and potassium intakes were found to be 
significantly different at the 5% confidence interval. Sodium was 
the only nutrient consumed within the recommended level by all 
groups. Iron, zinc, the B group vitamins and the percentage of 
protein from high biological value sources were consumed below 
the recommendations. The proportion of fat consumed as 
saturated fat was higher than ideal and the total energy intake 
was found to be largely inadequate in all groups. 
Ill 
The results have implications for future research and for 
dietetic practice in the clinical setting. Future directions for 
research may well concentrate on the identification of factors 
influencing the capacity and motivation of individuals to adhere to 
dietary restrictions and how best such information can be applied 
to dietetic counselling. Perhaps a shift in focus to a positive 
message, emphasising consumption of an adequate intake rather 
than simply restriction of various nutrients necessary. This may 
result in a more efficient and effective nutrition education service 
and possibly in improved nutritional status in the haemodialysis 
population. 
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Chapter 1 
I n t r o d u c t i o n 
Background and Statement of the Problem 
Within the Hunter region haemodialysis population a number 
of deaths due to episodes of hyperkalemia prompted a team of 
researchers at John Hunter Hospital, Newcastle to investigate the 
seasonal variation in potassium intake and to postulate links with 
elevated serum potassium. Chronic renal disease can have severe 
metabol ic consequences. Of these, high serum potassium 
(hyperkalemia) may prove fatal. 
A study was developed which, among other factors, involved 
measuring dietary intakes of haemodialysis patients. This provided 
an opportunity to investigate intakes of certain nutrients, namely 
those affecting nutritional status and renal failure progression. It 
was also possible to assess how closely haemodialysis patients 
adhere to dietary restrictions placed on them. An analysis of the 
breakdown of intakes between the three categories of haemodialysis 
patients, those being home, centre and limited care, would establish 
whether there is a particular group in need of further attention 
and/or education in the dietary aspects of recommended treatment. 
Significance of the Study 
Many studies define the recommended intakes of nutrients and 
describe the adverse affects of elevated intakes and subsequent 
serum levels, however, there are fewer studies published on the 
actual intakes of selected nutrients of renal patients. Results of this 
project will give the renal dietitian a view of actual intakes within 
this population, raising issues of dietary adherence to the 
recommended intakes and question the patient decision-making 
process. Suggestions are made regarding the main focus of 
counselling to a more positive message for the renal patient. 
Definition of Terms 
'Hyperkalemia' refers to dangerously elevated serum potassium 
levels. If untreated, this may lead to arrythmias or cardiac arrest. 
'Limited Care' refers to patients visiting the Wansey Centre, 
Newcastle on an outpatient basis several times per week. These 
patients are able to operate dialysis machines and undertake the 
procedure of dialysis with minimal assistance. 
Limitation of the Study 
1. Small sample size. The sample size was appropriate for a 
clinical study on potassium status, however it was very limiting for 
assessing nutrient intakes. 
2. Lack of inter-rater reliability checks. Inter-rater checks were 
not conducted to determine reliability between the three 
interviewers. An Interviewer's Manual was aimed at maximising 
reliability. 
3. Data entry errors. Assumptions were made at computer data 
entry stage when insufficient detail given. A questionnaire was 
administered to minimise such assumptions. 
4. Validity of test measure. Validity of the Food and Drink Diary is 
questionable, however it was felt to be the best method for dietary 
intake assessment as yet. 
5. Pilot test for questionnaire. A pilot test was not conducted on the 
questionnaire due to resourse constraints. There were no problems 
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2 . 1 I n t r o d u c t i o n 
A major area of nephrology research in the past decade has 
been directed at studying ways of slowing renal function 
deterioration in previously diseased or damaged kidneys. It has 
been known for years that when a critical number of nephrons 
are destroyed or lost from any cause, even if the initiating event 
has been eradicated, the remaining nephrons, although normal at 
the time, will ultimately be destroyed (Alfrey, 1988). 
Many factors that may explain the progressive nature of 
chronic renal disease have been identified or suggested. They 
include haemodynamic adaptations (increased glomerular 
pressures and flows), metabolic abnormalities (deposition of 
calcium and phosphate salts in renal parenchyma, deposition of 
urate salts in renal interstitium, and perhaps abnormalities of 
lipid and prostaglandin metabolism), immunologic alterations 
(immune response against renal antigens), and coagulative 
disorders (thrombosis of glomerular capillaries) (Anderson et. al., 
1985). 
The traditional attempts to modify some of the alterations 
have been addressed by pharmacological agents. Manoeuvres 
other than the use of pharmaceutical agents have been shown to 
be even more effective in preventing renal function deterioration. 
One of these is dietary manipulation, which can include restricting 
proteins (Brenner et al., 1982), phosphate (Ibels et. al., 1978), 
sodium, potassium and substituting lipids (Alfrey, 1988). All of 
these different dietary manipulations have been shown to be 
effective in slowing or preventing renal function deterioration 
either directly or indirectly. 
Prescriptions of appropriate diet therapy is a conservative 
way to help the kidney compensate for the altered pattern of 
renal metabolism. Unfortunately, severe constraints upon eating 
habits are poorly tolerated, not only for social reasons but also 
because they affect the supply of essential nutrients, often leaving 
the patient under the recommended daily intakes for energy in 
particular, but also other vitamins and minerals (Kinney et al., 
1988). 
This study measured the dietary intakes of selected 
nutrients in a sample of haemodialysis patients in the Hunter 
region. Intakes of protein, phosphate, sodium, potassium, and 
saturated fat were analysed, as well as the intakes of related 
nutrients such as iron, dietary fibre and total energy intake. A 
comparison was made as to how closely patients adhered to the 
recommended intakes of these nutrients for patients on 
haemodialysis. 
2 . 2 The Remnant Kidney 
The management of patients with renal disease is firmly 
grounded on the understanding of renal physiology and how renal 
function is disturbed by the disease process. 
The kidneys are essential for maintaining many aspects of 
the internal chemical environment of the body. The main function 
is for the excretion of nitrogenous metabolites and surplus 
nutrients, the regulation of water and body electrolytes and 
metabolic homeostasis. As an excretory organ, they remove such 
waste products of nitrogen metabolism as urea, uric acid and 
creatinine, as well as hydrogen ions and sulphates which arise 
from the degradation of sulphur-containing amino acids. They 
also excrete and regulate surplus quantities of water, sodium, 
potassium, calcium, phosphate, magnesium and other ions. By 
modifying the composition of the urine they maintain not only the 
volume of the body fluids but also the electrolyte composition 
within very narrow limits. 
The kidneys are the exclusive site for the production of 1,25 
dihydroxy vitamin D, the most active metabolite of the vitamin 
which acts on the intestine to increase calcium absorption and 
therefore maintain normal mineralisation of the bone. They also 
produce erythropoietin and renin, and several hormones including 
parathyroid hormone, calcitonin, insulin and gastrin which are 
degraded in the kidney. 
As renal function becomes impaired, many complex 
biochemical changes occur, some being responsible for the clinical 
features observed in chronic renal failure. These changes include 
disturbances in hydrogen ion concentration, elevated serum levels 
of nitrogenous waste products and abnormalities in water and 
electrolyte balance. In addition, renal failure is accompanied in 
the majority of cases by arterial hypertension, and this 
complicates the clinical picture further. 
The kidneys have a large functional reserve, and the body 
can tolerate a considerable accumulation of waste metabolites. In 
consequence, few patients develop symptoms of renal failure until 
the glomerular filtration rate has fallen below 10 mis/minute or 
90 per cent of the capacity for eliminating urea and creatinine has 
been lost. Once this degree of degradation has been reached, 
maintenance treatment by means of peritoneal dialysis or 
haemodialysis must be considered. Peritoneal dialysis or 
haemodialysis refer to the two different ways in which urea, 
creatinine and other water-soluble substances of small molecular 
weight can be removed from the blood by diffusion across the 
semi-permeable membrane into a dialysate fluid that can be 
drained away. In haemodialysis, the blood is taken from the 
patient and passed through a haemodialyser in which the blood is 
separated from the dialysis fluid by an artificial cellophane 
membrane (Passmore et al., 1986). It is preferable to start 
haemodialysis before wasting and malnutrition is severe. 
Improving nutritional status becomes more difficult once dialysis 
is commenced (Birks, 1990). 
Haemodialysis treatment replaces renal function in terms of 
excretion of nitrogenous metabolites and the correction of acidosis 
to the extent that patients can enjoy a relatively normal protein 
intake. Their capacity for the excretion of drugs and surplus 
quantities of water, sodium, potassium and phosphate is limited. 
Thus, some limitation of dietary intake is often necessary and 
vital nutrients removed during dialysis must be replaced. The 
metabolic functions of the kidney cannot, however, be replaced 
such as the synthesis of erythropoietin and the conversion to 1,25 
dihydroxy vitamin D. Nevertheless, renal function is sufficiently 
replaced by these artificial means to enable most patients to stay 
not only alive but well and able to continue normal employment 
and family life for many years. 
The nutritional assessment of patients undergoing 
haemodialysis has revealed a susceptibility to poor nutrition. This 
may result from a poor dietary intake, endocrine abnormalities 
and the effect of haemodialysis itself (Allman, 1989). The main 
objective of dietetic treatment in dialysis is to maintain protein 
and energy equilibrium, to maintain near normal potassium and 
sodium levels and to prevent fluid overload or dehydration. 
Serum phosphate and calcium levels and the intake of saturated 
fat are to be kept within acceptable levels. The requirements of 
selected major nutrients and minerals are considered. 
2 . 3 Influence of Dietary Management on the Progression 
of Chronic Renal Failure 
2.3.1 Protein and Phosphate 
It was a general experience that once renal failure had 
advanced to a certain point, further deterioration was almost 
inevitable even if the underlying cause is removed and 
complicating factors, such as hypertension, were controlled. It has 
been reported that in most cases of chronic renal insufficiency, the 
reciprocal of serum creatinine declined linearly with time (ie. the 
rate of deterioration was constant) and that this linear decrease 
was observed even as renal failure became nearly terminal (Mitch 
et al., 1976). This observation made it possible to estimate the 
effect of therapy on progression in individual patients. 
Until recently the aims of nutritional management in chronic 
renal failure have been to optimise the nutritional status of the 
patient and/or alleviate uremic toxicity. Recently, however, 
several experimental and clinical studies have shown that the 
course of renal failure may be affected by dietary change. Thus, it 
was demonstrated that phosphate restriction can prevent the 
deve lopment of inters t i t ia l nephropathy in subtotal ly 
nephrectomised rats, presumably because deposition of calcium 
phosphate in the tissues was prevented (Ibel et al., 1978). It has 
also been shown that the progression was retarded in patients 
treated with a phosphate-restricted diet (Maschio et al., 1982) and 
it has been suggested that improved control of serum phosphate 
and reduction of the calcium phosphate product might be involved 
in the retardation of renal failure (Walser, 1980). Likewise, the 
progression of renal failure has been slowed in patients treated 
with protein restriction supplemented with essential amino acids 
or keto acid preparations (Kluthet et al., 1971, Barsotti et al., 1981, 
Alvestrand et al., 1983, Fouque et al., 1992). The effect of the 
restriction of protein and phosphate has not been clearly 
separated, since dietary restriction of phosphate entails restriction 
of protein and vice versa. The lack of effect of treatment with a 
low phosphate diet on the progression of renal failure in some 
patients suggested that preservation of renal function may be 
mediated by restriction of dietary protein per se (Barrientos et al., 
1982). 
Hostetter et al. (1982) have speculated that the final 
common outcome of chronic renal disease depended upon some 
critical loss of renal mass. Compensatory hyperfusion of remnant 
glomeruli might result in sclerotic destruction. This suggestion 
was supported by the observation that in partially 
nephrectomised rats severe restriction of dietary protein intake 
can partly prevent glomerular hyperfiltration and reduce the 
structural abnormalities in remnant glomeruli. This effect was 
apparently not dependent on improved phosphate control, since in 
this study the phosphate content of the low protein diet was 
similar to that of the control diet. It should be emphasised that 
the effect of protein restriction on glomerular hyperfiltration in 
remnant nephrons was found in rats with experimental renal 
failure and there was lack of evidence that the same mechanism is 
operating in human renal failure. It cannot be excluded, however, 
that the hyperfiltration hypothesis may also be relevant to 
patients with chronic renal failure. Available clinical data from 
different groups, although anecdotal or not well controlled, 
strongly suggests that progression of end-stage renal failure in 
humans may be retarded or halted by treatment with a low 
protein diet supplemented with amino acids or keto acids (Barsotti 
et al., 1981, Alvestrand et al., 1983). Since acute enhancement of 
glomerular filtration occurs after a protein meal (Pullman et al., 
1954, Bergstrom et al., 1985) it is conceivable that hyperfiltration 
and further destruction of the renal parenchyma may be avoided 
by or delayed by the protein restriction. This may have 
important implications in the future, especially if it can be shown 
that this principle of treatment is operable in early renal disese as 
well. 
To date, there has only been one prospective randomised 
trial of early dietary protein restriction (Rosman et.al., 1984). 
This study of 228 patients showed that moderate protein 
restriction (0.4 - 0.6 g/kg body weight) retarded the development 
of end-stage renal failure if instituted early in the course of renal 
failure. While Allman (1989) identified several problems in the 
study with most dissent about the criterion (ie. the reciprocal of 
serum creatinine) used, Mitch et al (1976) found this criterion to 
be an accurate determination of renal failure progression. 
Currently two major multi-centre trials are being conducted 
into the effect of protein intake on renal function deterioration; 
one by the European Study Group for the Conservative 
Management of Renal Failure and the second being funded by the 
3 0009 03100 9389 
U.S. National Institute of Health, in response to a congressional 
mandate. The results of both studies are expected in late 1993. 
In chronic renal failure, as the glomerular filtration rate 
decreases and fewer nitrogenous waste products are excreted, it 
becomes necessary to control the level of protein intake while 
continuing to maintain a positive nitrogen balance. A mild protein 
restriction is usually initiated when the renal function has 
decreased to about 25 per cent of normal, and protein is 
decreased further as renal function continues to decline, as 
measured by creatinine clearance. Therefore, the renal failure 
patient may restrict his protein intake in stages as renal failure 
progresses. 
At least 70 per cent of the protein intake should be of high 
biological value (HBV) or complete proteins to assure that the 
essential amino acid requirements are met (Zeman, 1991). The 
body then uses its extra nitrogen to synthesise the non-essential 
amino acids and thus reduces the amount of urea that must be 
removed. While the intake of high biological value (HBV) and low 
biological value (LBV) proteins is important, most patients find it 
difficult, if not impossible, to consume adequate energy and still 
have a palatable diet. In addition, the uraemia itself causes some 
taste aberrations, noticeably to red meats, making the HBV/LBV 
ratio difficult to achieve (Krause et al., 1986). 
Dialysis is a drain on body protein, and daily intake should 
be increased to compensate for this. It is generally agreed that 
haemodialysis patients require 1.0 to 1.2 grams of protein/kg 
'ideal' body weight /day. This is higher than the requirements of 
normal healthy individuals (0.75g/kg) the reason being that 
haemodialysis patients suffer losses of amino acids during the 
dialysis procedures. It is estimated that 1 gram of protein is lost 
in the dialysate for every hour on dialysis. Patients are also prone 
to gastrointestinal and dialysis blood losses and the contact of 
blood with the dialysis membrane is a catabolic stimulus (Kluthet 
et al.,1978. Ward et al., 1979, Allman, 1989). 
A study by Allman (1989) revealed a protein intake of 1.2 
g protein/kg body weight in a sample of maintenance 
haemodialysis patients (n=50). This compared favourably to 
in ternat ional studies of protein intake of maintenance 
haemodialysis patients (Allman, 1990). Australian haemodialysis 
patients had the highest protein intake (Allman, 1989) of 1.2 g 
protein/kg, compared with their counterparts in Germany (0.9 
g/kg) (Schaeffer et al., 1975), Italy (1.23 g/kg) (Guarnieri et al., 
1980), U.S.A. (1.0 g/kg) (Thunberg et al., 1981, Wolfson et al., 
1984) and New Zealand (0.8 g/kg) (Doube, 1985). A New Zealand 
study of the nutritional status of home haemodialysis patients 
recorded an intake of 1.3 g/kg or 87 grams of protein per day 
(Talemaitoga et al., 1989). 
Phosphate intake is often also restricted. Serum phosphate 
levels must be kept below 2.0 mmol/L. Above this level, calcium 
and phosphate salts precipitate in extraskeletal tissues, ultimately 
causing irritation of the conjunctiva and red eyes, vascular 
calcification, unsightly periarticular swellings and pseudogout 
(Passmore et al., 1986). On the other hand, too little dietary 
phosphate, which can result from excessive limitation of protein 
intake, can result in phosphate depletion and skeletal 
déminéralisation resembling osteomalacia. Serum phosphate 
levels are routinely controlled with phosphate-binding gels or 
calcium carbonate, binding with phosphate and preventing its 
absorption from the gut. Frequently patients may have to take 
large quantities of phosphate binders (20 tablets per day) in order 
to keep the serum phosphate under control (Krause at al., 1986, 
Weinsier et al., 1989). 
A potential risk of excessive consumption of these 
phosphate binders is severe constipation leading to intestinal 
compaction. Occasionally, this may lead to perforation of the 
intestine, with resultant peritonitis and death (Krause et al, 1986). 
An intake of 1000 - 1200 mg phosphate is recommended for 
maintenance haemodialysis patients (D.A.A. No 6 Clinical 
Handbook, 1990). 
2.3.2 Potassium 
Normally, the kidney provides the major route for 
potassium excretion. In renal failure, potassium retention may 
occur and may lead quickly to fatal hyperkalemia. Two factors 
may prevent this occurrence in renal failure. First, as long as 
urine output remains at approximately 1000 mis/day or greater, 
tubular secretion of potassium in the remaining functioning 
nephrons tends to be increased, and therefore the renal potassium 
clearance does not fall as markedly as the glomerular filtration 
rate (GFR). The haemodialysis patient is often oliguric (produces 
insufficient urine) or anuric (produces no urine), and therefore 
would not have this protection. Second, faecal excretion of 
potassium is increased owing to enhanced intestinal secretion. 
Thus, patients with chronic renal failure may become 
hyperkalemic if there is (1) excessive intake of potassium; (2) 
acidosis, oliguria, or hypoaldosteronism or (3) catabolic stress 
(Shils et al., 1988, Zeman, 1991). 
The renal failure patient is cautioned severely against the 
consumption of large quantities of foods rich in potassium. The 
use of potassium-sparing medications or of salt substitutes 
containing potassium may be a factor. Since potassium is 
"exchanged" for sodium in the distal tubule, insufficient sodium 
may decrease potassium excretion with resultant hyperkalemia 
(Zeman, 1991) 
Most of the potassium in the body is located in the cells, and 
the balance between intracellular and extracellular fluid 
concentrations is governed by the prevailing state of acidosis or 
alkalosis. Between dialysis treatments, hydrogen ions accumulate 
causing a slight shift of potassium from the cells and a substantial 
rise in plasma potassium. The degree of hyperkalemia is quite out 
of proportion to the 10-15 per cent increase in total body 
potassium represented by the 200-300 mmol ingested over the 3-
4 day period between dialysis treatments. 
In late renal failure, when oliguria supervenes, potassium 
balance becomes precarious. Control is essential, since high serum 
potassium levels cause arrythmias and possible cardiac arrest 
(Zeman, 1991). Patients undergoing haemodialysis, in general, 
should receive no more than 60 mmoles of potassium per day or 
1 mmole per kg reference body weight (D.A.A. No 6 Clinical 
Handbook, 1990). Talemaitoga et al (1989) recorded an 
intake of 65 mmoles per day in a sample of thirty-eight home 
haemodialysis patients. 
2.3.3 Sodium 
Sodium is freely filterable by the glomerulus. In the normal 
kidney, the renal tubules reabsorb well over 99% of the filtered 
sodium (Shils et al., 1988). As renal insufficiency progresses, both 
the glomerular filtration and fractional reabsorption of sodium fall 
progressively. Thus, many patients with renal failure are able to 
maintain sodium balance with normal intake. Normally 1-3 
mEq/day of sodium are excreted in the faeces, and in the non-
sweating individual, a negligible amount is lost through the skin. 
Despite an adaptive reduction in the renal tubular reabsorption of 
sodium when end-stage renal disease supervenes, patients may 
be unable to excrete the quantity of sodium ingested, and they 
may develop oedema, hypertension or congestive heart failure. 
This syndrome is particularly likely to occur when the GFR is 4 to 
10 mls/min, at which stage dialysis is a probable treatment (Shils 
et al., 1988, Zeman, 1991). 
Sodium intake should be limited to 70-100 mmoles per day 
to control hypertension (Kohlhardt, 1992). A sodium intake of 
114 mmoles per day has been recorded in home haemodialysis 
patients (Talemaitoga et al., 1989). 
2.3.4 Lipids 
Hyperlipidemia is a common manifestation of renal disease, 
defining the importance of recognising the role of lipid 
abnormalities in the pathogenesis of glomerular injury and thus 
the progression of renal disease. Haemodialysis patients have a 
high incidence of Type IV hyperlipoproteinemia with elevated 
serum triglyceride levels, a low serum high-density lipoprotein 
(HDL) cholesterol, and elevated serum low-density lipoproteins 
(LDL) and very low-density lipoproteins (VLDL) (Kinney et al., 
1988). Because these alterations may contribute to the high 
incidence of atherosclerosis and cardiovascular disease in uraemic 
patients, attention has been directed towards reducing serum 
triglycerides and increasing HDL cholesterol. Elevated serum 
triglyceride levels in uraemia appear to be caused primarily by 
impaired clearance from blood. In addition, because diets in renal 
failure are usually restricted in protein, sodium, potassium and 
water, it is often difficult to provide sufficient energy without 
resorting to a large intake of simple sugars that may increase 
triglyceride production. Kinney et al.(1988) suggest serum 
triglycerides may be lowered by a diet in which carbohydrate 
content is reduced to as low as 35% of total kilojoules, and fat 
content increased to about 55% of total kilojoule content, with a 
polyunsaturated/saturated fatty acid ratio raised to about 2:1. 
This restriction seems extreme, however it is generally accepted 
that saturated fat intake should be limited to less than 10 per cent 
of total kilojoule intake among the general population and for 
haemodialysis patients (Zeman, 1991). While saturated fat intake 
should ideally be restricted, the guidelines for patients in the 
Hunter region is that it is not of prime importance in the renal 
diet unless a cholesterol lowering diet is requested by the 
physician (Calverley, 1992 - pers. comm.). 
Ciman et al (1980) and Bellinghieri et al. (1983) report that 
serum triglycerides may be lowered if dialysis patients take L-
carnitine, a compound found to be low in dialysis patient's plasma 
and possibly muscle. Ingestion of activated charcoal may lower 
serum cholesterol and triglycerides in chronically uraemic rats 
(Mavis et al., 1980). Clofibrate also lowers serum triglycerides in 
uraemic patients, but owing to the altered pharmacokinetics of 
this drug, there is a high risk of developing myopathy or other 
toxicities (Pierides et al., 1979). 
Studies have not been performed to evaluate whether 
lowering serum triglycerides will improve morbidity and 
mortality in uraemic patients, and a high intake of fats may 
increase the risk of atherosclerotic vascular disease in these 
patients (Shils et al, 1988). Though dietary modification to delay 
or prevent these adverse effects seems to be a logical procedure, 
planning is difficult. Fat is often used to make up the energy 
deficit experienced with the extensive dietary restrictions placed 
on the patients with renal disease. Diets low in saturated fats 
have shown to reduce serum lipids and retard the progression of 
renal disease in early renal failure (Ward, 1990, Kohlhardt, 1992). 
2.3.5 Total Energy 
Energy intake must be adequate in order to spare protein 
for tissue protein synthesis and prevent its metabolism for 
energy. Alternative fuel sources that will prevent this use of 
protein for energy production must come from a high intake of 
carbohydrates and fats (Krause et al, 1986). Depending on the 
patient's present nutritional status and degree of stress, an intake 
of 146 - 167 kilojoules per kilogram of "ideal" body weight is 
recommended (Kohlhardt, 1992). 
Allman (1989) states the average energy intake in a sample 
of maintenance haemodialysis patients as 138 kJ/ kg body weight. 
A finding in Allman's study was that poor intakes were due partly 
to a misconception of the dietary advice as having focused on the 
restriction of food. Some patients claimed to have decreased food 
intakes because they had been rebuked about excess weight gain 
between dialysis. Many patients find the "renal" diet unpalatable 
with the restriction of protein, phosphate, sodium and potassium 
compared to the "regular" diet (Sanders et al., 1991). 
Talemaitoga et al (1989) found an energy intake of 119 
kJ/kg among a sample home haemodialysis patient as largely 
inadequate . 
2.3.6 Dietary Fibre 
Studies in the normal population suggest that a high dietary 
fibre intake may cause a lower incidence of constipation, Irritable 
Bowel Syndrome, diverticulitis and neoplasia of the colon and 
possibly a greater glucose tolerance (Shils et al., 1988). Because 
the patient with renal failure may benefit from fibre intake, an 
ideal intake is 30 grams of total dietary fibre (Calverley, 1992 -
pers. comm.). This amount may not be tolerated because of the 
potassium content. 
2.3.7 Iron 
Anaemia is a common finding in uraemic patients. The 
major cause is apparently bone marrow failure due to decreased 
erythropoietin production in the kidney. Without the stimulation 
of erythropoietin, the bone marrow fails to produce red blood cells 
from its stem cells. Reduced iron absorption, frequent blood 
sampling and gastrointestinal blood loss (especially if the patient 
is taking medication with salicylate compounds) also contribute to 
severe anaemia (Shils et al., 1988). Haemodialysis patients may 
have a low iron intake secondary to anorexia, nausea and 
vomiting and dietary restrictions (Kinney et al., 1988). Iron 
supplementation may be given either orally bound to ascorbic 
acid or intravenously, however may not be necessary if the 
patient is having regular blood transfusions. Clearly, it is 
important that the patient have an adequate diet to avoid 
increasing the severity of malnutrition (Zeman, 1991). 
2.3.8 Zinc 
Zinc concentration is low in plasma, leucocytes and hair in 
uremic patients. This may be a factor in the reduced taste acuity 
and sexual dysfunction of such patients, often caused by protein 
restriction and by losses in the dialysate (Birks, 1991, Weinsier et 
al., 1989). Oral administration of zinc is relatively ineffective in 
restoring normal zinc levels and therefore is not commonly 
supplemented (Walser, 1983). 
2.3.9 Thiamin. Riboflavin and Niacin 
Deficiencies of water-soluble vitamins may be due to poor 
food intake, altered metabolism and losses in dialysate. A survey 
of Australia's major renal units revealed that many differences in 
supplementation practice as regards the actual vitamins 
supplemented and the doses given (Allman, 1989). As with drugs 
administered to renal patients, due regard must be paid to the 
potential toxicity of water-soluble vitamins in patients who do not 
have a normal excretory capacity. It is recommended that water 
soluble vitamins be given at a dose close to the Recommended 
Daily Intake (R.D.I.) for healthy people to avoid harmful effects 
(Allman, 1990, Birks, 1991, Weinsier et al., 1989). 
2 . 4 Adherence to Dietary Restrictions 
Few chronic treatment plans are as complex and demanding 
as those prescribed for chronic dialysis patients. The frequency 
and duration of dialysis, dietary and fluid restrictions, multiple 
medication needs, episodic access procedures and various other 
testing and treatment requirements are components of each 
patient's treatment regimen. Given the potential consequences of 
non-compliance for patients with regard to morbidity and 
mortality, for families with regard to psychosocial stress, and for 
society with regard to health care costs, there is little doubt that 
the topic of compliance is integral to a discussion of dialytic care 
(McKevitt et al., 1990) 
In the compliance literature, studies have focussed on a 
wide range of issues, including methods to measure compliance 
(Agashua et al., 1981, Cummings et al., 1984, Ruff, 1983), levels of 
patient compliance (Blackburn, 1977, Procci, 1978), factors 
influencing adherence to dietary regimens (Steidl et al., 1980, Poll 
et al., 1980, Yanagida et al., 1981, Kaplan-De Nour et al., 1972, 
Cummings et al., 1982), predicting compliance (Schleusch et al., 
1982, Hartman et al., 1978) and intervention strategies to 
improve compliance (Cummings et al., 1981, Noble et al., 1983, 
Keane et al., 1981). 
The degree of dietary compliance reported in patients with 
various medical conditions varies, in part, depending upon which 
measures of dietary compliance are used. Estimates of dietary 
compliance in haemodialysis patients have ranged from 28 to 70 
per cent of that population (Haynes et al., 1979). 
Psychological , environmental and social factors and 
characteristics of the therapeutic regimen and the health 
p ro fess iona l -pa t i en t re la t ionship may all be important 
determinants of compliance (Gillum et al., 1974, McKevitt et al., 
1990). Attempts to identify specific personality types that can be 
correlated with compliance or noncompliance with diet or other 
aspects of medical treatment have not been successful (Porter, 
1969). Marston (1970) states that neither age, sex, socioeconomic 
status, education, religion, marital status, nor race have been 
shown to predict compliance. Cummings et al. (1982) found that 
there was some correlation with age, with older patients being 
better compilers. Also, knowledge of the disease has not 
correlated well with compliance with treatment. It may be that 
the patient's attitude towards the disease and treatment are more 
important than factual knowledge with regard to the degree of 
compliance. It has been suggested that noncompliers tend to 
perceive themselves as less susceptible to or less threatened by 
actual or potential illness (Becker et al., 1975). 
2 . 5 Selection of Diet Survey Methods 
To compare actual dietary intakes to recommended dietary 
intakes of selected nutrients, a three day Food and Drink Diary 
was administered. There are several reasons for this choice of 
diet survey method. 
A Food and Drink diary is relatively easy to complete and 
therefore is applicable to a wide population group, regardless of 
age, education or cognitive abilities. Field survey costs are 
minimal in comparison to some other intake methods, with an 
estimated average time for an interview approximated at 35 
minutes. Only one interview is required per patient. It does not 
rely on memory. Retrospective methods carry the risk of dietary 
information containing inaccuracies because of reliance on 
memory (Krause et al., 1986). There are, however, some 
limitations of this method, including high subject co-operation and 
problems encountered with changing of consumption patterns. 
Food diaries have been recorded as an accurate and reliable 
method of assessing intake (Krall et al., 1987, Sorenson, 1985, 
Bergman, 1990). The diary proves to be a reliable method by 
giving acceptable agreement with actual consumption, reported in 
studies in which intakes were directly observed (Krall et al., 
1987). The representativeness of data derived from a three day 
Food and Drink diary has been found to be relatively accurate 
(Krause et al., 1986). The length of time a diary must be kept in 
order to accurately reflect usual intake depends upon the 
variability of intake and reaching a compromise between accuracy 
and patient reliability and co-operation. 
In a study by St Jeor et al (1983), the variability in intake of 
selected nutrients was examined over a 28 day period. 
Conclusions reached showed no significant difference in intake of 
the nutrients from week to week over a four week period, and 
that four day diaries were the best representation of usual intake. 
Bergman et al (1990) concluded from a comparative study 
of diet survey methods that three day diet records are the most 
appropriate for studies involving moderate to large groups. 
Jackson et al (1986) assessed relative reliability of diet records for 
monitoring lipid and caloric intake. It was found that three day 
recording gave information approximating seven day records. 
Gersovitz et al (1978) recommends no longer than a three day 
record when sampling an elderly population. 
The research design as stated by the research team at John 
Hunter Hospital was to include a three day Food and Drink diary. 
While some literature cites a four day diary as being the more 
representative length of time (St Jeor et al., 1983, Hyman et al., 
1982), the three day diary was a compromise between the more 
elaborate seven day record and an accurate assessment of intake 
while trying to maintain reliability and patient co-operation. 
2 . 6 C o n c l u s i o n 
It has been reasonably well established that there are some 
secondary and compensatory events resulting from loss of 
nephron population that may be harmful to the remaining 
nephrons, ultimately causing their destruction. It is becoming 
increasingly clear that a variety of dietary manipulations may 
exert a protective effect, preventing progressive functional 
deterioration in a decreased or damaged kidney. 
Adherence to dietary restr ict ions placed on the 
haemodialysis patient is necessary for the physiological 
management of disease. Using a three day Food and Drink Diary 
to assess the intake of certain nutrients affecting renal function, 





M e t h o d 
The aim of the study was to measure the dietary intakes of a 
sample of haemodialysis patients and compare to recommended 
intakes. Using tests to determine any statistical significance between 
the actual and the recommended intakes and within the three 
dialysis categories, it can be determined whether the sample adhered 
to the recommended intakes and if there were any differences 
between groups. 
Ethics 
The study was approved clearance by the Hunter Area Health 
Service Ethics Committee and also by the University of Wollongong 
Human Experimentation Ethics Committee, approval number HE 
92/17, March, 1992. The patients gave written, informed consent for 
participation in the study (refer Appendix 2). 
Subjects 
The study population consisted of 37 chronic renal failure 
patients representing 38% of the entire current dialysis population 
with proportional representative samples taken from each of the 
three main dialysis groups (14 from Home dialysis, 11 from Limited 
Care Dialysis Wansey Centre patients, and 12 John Hunter Hospital 
Centre Dialysis patients). It was planned for a total subject 
population of 60 patients, however numbers were limited due to 
failure to meet the inclusion criteria. 
All current ly listed dialysis pat ients were ranked 
alphabetically and assigned consecutive numbers by ordinal ranking 
in each of the three dialysis categories and randomly selected for 
participation after those not meeting the criteria were excluded. 
Criteria for exclusion were that subjects had been acutely unwell 
and/or hospitalised for the last fortnight ie. a major medical stressor 
(eg. infarct or diabetic ketoacidosis), were less than three months 
into end stage renal disease maintenance haemodialysis or had acute 
infection at the time. All dialysis patients were advised of the study 
by letter from the Nephrologist in the research team and those 
subjects selected for participation were approached by members of 
the dietetic team. At all times it was emphasised that participation 
was an entirely voluntary matter and in no way affected patient 
status at the centre or hospital. 
The sample population was evenly distributed between males 
and females. Fifty one per cent of the sample were males (n=18) and 
49 per cent were females (n=17)(refer Appendix 1). Of the 37 
patients initiating the study, all completed the Food and Drink diary. 
This response rate of 100% is thought to be attributable to the strong 
rapport between patient and the renal dietitian and also due to the 
co-operation of the patients' nephrologist. 
Research Design 
After admission to the study, the volunteer subjects were 
asked to complete a three day Food and Drink Diary (refer Appendix 
3). The three days included two non-dialysis days and one dialysis 
day. Patients were asked to detail all foods eaten and drinks 
consumed during the three day period, how they were prepared and 
where they were consumed. The diaries were analysed using Diet 1 
(NutTab 1992) Dietary Computer Package. 
A short questionnaire was also completed by each patient 
detailing food preparation techniques and types of foods consumed 
(refer Appendix 4). The questionnaire was not pilot tested prior to 
administration due to resource constraints, however there were no 
problems experienced with the questionnaire design. Type of bread 
(eg. white, brown or wholemeal), type of milk (skim, reduced fat or 
whole milk), number of teaspoons of sugar in tea or coffee and 
amount of milk taken with cereal were typical questions asked. The 
questionnaire was designed as an adjunct to the diary to clarify 
details when insufficient information was provided, thus eliminating 
assumptions of data entry into the computer. 
An In terv iewer ' s Manual was developed to minimise 
variability between interviewers (refer Appendix 5). As there were 
three individuals interviewing and training patients in methods of 
accurate recording of the diary, it was necessary to have a manual to 
assure uniform instruction. 
Data Analysis 
The data analysed was the results of the dietary intakes 
recorded using the three day Food and Drink Diary and analysed by 
Diet 1 (NutTab 1992) Dietary Computer Package. The results were in 
the form of intakes of macronutrients, vitamins and minerals 
consumed over the three day period. Selected nutrients of protein, 
phosphorus, potassium and sodium were considered in detail, and 
assessed as to how closely the dialysis population adhered to the 
recommended intakes. Iron, zinc, B vitamins, high biological value 
protein, dietary fibre, per cent saturated fat and total energy intake 
were also analysed. 
Statistical tests were used to determine significant difference in 
intake between the three categories of the haemodialysis population. 
Data were analysed using the Stat View 512 Computer Package. 
As the distribution of data was neither normal nor non-normal, both 
parametric and non-parametric tests were calculated. As results 
were similar in both cases, reports of parametric tests were selected 
for presentation. 
For each of the selected nutrients, tests compared the intakes 
of the haemodialysis patients to the recommended intakes. A one-
sample T-test (parametric) and a Wilcoxan-Signed Rank Test (non-
parametric) compared the mean actual intake of each nutrient to a 
standard intake. 
To determine whether there was any difference in intakes 
between the three categories of haemodialysis patients, a one factor 
Analysis of Variance and a Kruskal-Wallis test was performed. 
Correlations between intakes of selected nutrients was measured 
using a Pearson's Correlation Coefficent and a Spearman's Correlation 
Coefficient. 
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The study was a cross-sectional assessment of the nutritional 
intake of haemodialysis patients at a major teaching hospital using 
estimated records of dietary intakes (three day diary quantitated 
with household measures). 
It showed that a considerable proportion of patients had 
nutrient intakes which were outside the recommended ranges and 
that energy intakes were largely inadequate. 
Comparison of Actual Intakes to Recommended Intakes 
Intakes of protein, potassium and phosphate were lower than 
recommended levels, and showed a significant difference at the 5% 
confidence interval level between the study population's mean 
intake and the recommended intake. The mean sodium intake was 
within the range of the recommendation, with no significant 
difference demonstrated between mean sodium intake and the 
recommended range. 
Table 1 shows the actual intakes and the recommended intakes 
of protein, potassium, phosphate and sodium. 
Nutr ient Mean Intake(S.D.) Ree. Intake P Value (b) 
Protein (g) 54 (16) 67-80 (a) 0.0001 
Phosphorus (mg) 805 (268) 1000-1200 0.0001 
Sodium (mg) 81 (34) 70-100 0.5865 
Potassium (mmol) 39 (14) 60 0.0001 
(a) Based on 1.0 - 1.2 g/kg of mean body weight of population. 
(b) Where p < 0.05 = significant difference. 
Table 1. Comparison of Mean Actual and Recommended Intakes of 
Protein, Phosphorus, Sodium and Potassium. 
Table 1 shows the one sample T-Test results, where p < 0.05 
demonstrates a significant difference at the 5% level. A significant 
difference was found between the recommended and the actual 
intakes of protein, phosphorus and potassium, while no significant 
difference was demonstrated between actual and recommended 
intakes of sodium. 
The intakes of iron, zinc, B group vitamins, dietary fibre, total 
energy, percentage of high biological value protein and percentage 
saturated fat were calculated. 
The actual kilojoule intake of the population ranged from 5,300 
- 5,600 kilojoules (mean 5,400 kJ, standard deviation 1,700 kJ). This 
is considerably lower than the recommended intake range of 9,800 -
11,200 kilojoules. While total energy was inadequate, the saturated 
fat intake was elevated above the recommended proportion. Of the 
total energy derived from fat sources, the sample population had an 
intake of 41% from saturated fat. Dietary fibre intake averaged at 
12.8 grams, being considerably below the ideal intake of 30 grams of 
fibre per day. Intakes of iron and the percentage of high biological 
value (HBV) protein, zinc and the B group vitamins were below the 
recommended intakes. Table 2 details the actual and the ideal 
intakes of selected nutrients, and that there was a significant 
difference between the actual and the ideal intakes for all nutrients 
examined. 
N u t r i e n t Mean Intake(S.D.) Rec. Intake P Value (d) 
Saturated Fat (%) 41.0 (7) 10 0.0001 
H.B.V. Protein (%) 60.0 (46) 70 0.0002 
Iron (mg) 7.8 (3.6) 10-18 0.0001 
Dietary Fibre(mg) 12.6 (5.3) 30 0.0001 
Zinc (mg) 6.49 (2.6) 15 0.0001 
Thiamin (mg) 0.81 (0.4) 1.05 (a) 0.0056 
Riboflavin (mg) 1.09 (0.6) 1.60 (b) 0.0001 
Niacin Eq (mg) 12.9 (7.2) 16.80 (c) 0.0001 
Total Energy (kJ) 5,400 (1,700) 10,500 0.0001 
(a) Based on R.D.I, level of 0.10 mg thiamin per 1000 kJ. 
(b) Based on R.D.I, level of 0.15 mg riboflavin per 1000 kJ. 
(c) Based on R.D.I, level of 1.6 mg niacin equivalents per 1000 kJ. 
(d) Where p < 0.05 = significant difference. 
Table 2. Comparison of Mean Actual and Recommended Intakes of 
Selected Nutrients. 
Comparison of Nutrient Intakes Between Dialysis Categories 
No significant difference of nutrient intakes was found between 
the three categories of haemodialysis patients, namely centre, home 
and limited care. A one factor Analysis of Variance produced a 95% 
confidence interval and the Kruskal-Wallis test, using 2 degrees of 
f reedom, showed similar results. Appendix 6 graphically 
demonstrates the mean differences between dialysis categories for 
the nutrient intakes analysed. Table 3 details results of Analysis of 
Variance tests, demonstrating no significant differences. 
Nutr ient Mean Actual Intake (S.D.) P Value (a) 
Wansey L.C. Centre Home 
Protein (g) 51.6 (15) 57.6 (20) 51.3 (13) 0.5617 
Phosph. (mg) 763.0 (231) 876.0 (290) 748.0 (281) 0.4489 
PotassiumCmg 34.1 (12) 39.5 (16) 38.7 (14) 0.6305 
Sodium (mg) 72.1 (28) 96.8 (54) 76.0 (19) 0.2236 
Sat. Fat (%) 40.1 (8) 40.6 (6) 42.8 (6) 0.5854 
H.B.V.Prot.(%) 62.0 (15) 56.3 (14) 61.2 (16) 0.6206 
DietFibre(mg) 9.3 (3) 15.2 (8) 12.9 (4) 0.0658 
Iron (mg) 6.3 (2) 9.6 (6) 7.3 (3) 0.1387 
Zinc (mg) 624.0 (289) 728.0 (319) 573.0 (165) 0.3268 
Thiamin (mg) 61.8 (41) 103.0 (60) 74.2 (35) 0.1602 
R i b o f l a v i n ( m 92 .0 (55) 123.0 (92) 103.0 (49) 0.5325 
Niac inEq(mg) 1340.0 (837) 1453.0 (935) 1188.0 (381) 0.6587 
Energy (kJ) 5,300 (1,600) 5,600 (2,050) 5,400 (1,500) 0.9262 
Body Wt (kg) 67.0 (13) 63.0 (14) 70.0 (8) 0.3070 
(a) Where p < 0.05 = significant difference. 
Table 3. Comparison of Mean Nutrient Intakes Between Centre, 
Home and Wansey Limited Care Dialysis Categories. 
Correlation between Intakes of Selected Nutrients 
Correlations between intakes of selected nutrients was 
measured using a Pearson's Correlation Coefficent and a Spearman's 
Correlation Coefficient. No correlation was found between protein 
intake and per cent high biological value protein, or per cent 
saturated fat intake and patient body weight. There was a 
correlation demonstrated between potassium and dietary fibre 
intake (r= 0.77) and protein and iron intakes (r=0.69) (refer to 
Apendix 6). Table 4 shows the correlation coefficent test results. 
Correlation Between R Value 
Protein and %HBV Protein Intake 0.12 
Body Weight and %Saturated Fat -0 .07 
Potassium and Dietary Fibre 0.77 
Protein and Iron Intake 0.69 
Total Energy and Body Weight 0.18 
Table 4. Correlations Between Intakes of Selected Nutrients. 
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Malnutrition has been described frequently in patients 
undergoing haemodialysis, and poor dietary intake has been 
reported to be important among many factors responsible for 
wasting (Allman, 1989). Although the range of energy 
requirements for haemodialysis patients does not differ from that 
of healthy persons, the protein requirement has been estimated to 
increase. The "renal" diet for haemodialysis patients is often 
restricted in protein, sodium, phosphorus and potassium 
compared to the "regular" diet, and many patients find it 
unpalatable (Sanders et al., 1991). Requirements of the nutrients 
iron and zinc are higher than that for the healthy person, due to 
either the dialysis procedure or altered metabolism. Other factors 
for consideration in the renal diet are the contribution of 
saturated fat to the total energy intake, thiamin, riboflavin and 
niacin, dietary fibre and the proportion of protein intake from 
high biological value source. The intake of these nutrients 
affecting the nutritional status and/or renal function of the 
patient can be measured and, a comparison can be made between 
the actual and the recommended intakes of the nutrients to assess 
how closely haemodialysis patients adhered to the dietary 
restrictions placed on them. The results suggest that our 
recommendations and/or expectations are perhaps unrealistic, 
and that perhaps the emphasis in dietetic counselling should 
reinforce a positive message rather than focus only on restrictions. 
Dietary intake was assessed using a three day Food and 
Drink Diary. Estimated records of dietary intakes showed most 
nutrients were consumed below the standard and total energy 
intake was shown to be largely inadequate. 
The response rate to the Food and Drink Diary was 100%. 
This excellent result was thought to be attributed to the co-
operation of the patients' nephrologist and a good rapport 
between patient and the renal dietitian. The sample consists of 
proportional numbers of subjects from each of the three 
haemodialysis categories, namely home, centre and limited care 
pat ients . 
5.1 Energy Balance 
The average weight of the sample population was 67 
kilograms, with forty per cent below the reference weight for 
their sex. The average female weight was 61 kg (reference female 
weight 55 kg), and the average male weight was 70 kg (reference 
male weight 70 kg). It is important to remember that this is a 
crude classification of patient body weight, with data on height 
and age not recorded, thus limiting the accuracy for estimation of 
body weight classification. There are also some complications with 
measuring body weight in haemodialysis patients, as fluid balance 
is an issue. These body weights approximated well with a New 
Zealand study of home dialysis patients, with the mean male body 
weight of 72 kg and a female mean weight of 59 kg (Talemaitoga 
et al., 1989). An Australian study recorded 71 kg and 53 kg as 
the mean male and female body weights respectively (Allman, 
1989). Allman (1990) states that patients undergoing 
maintenance haemodialysis show a reduction in body weight 
reflected by decreased body fat and decreased body protein. It is 
well established that haemodialysis patients are at great risk of 
protein-energy malnutrition. Energy intake must be adequate in 
order to spare protein for tissue protein synthesis and prevent its 
metabolism for energy (Krause et al., 1986). The recommended 
energy intake for maintenance haemodialysis patients is set by 
D.A.A. at 146 - 167 kJ/ kg, thus giving a range of 9,800 - 11,200 
kJ/ day (Kohlhardt, 1991). The actual intake for the sample 
ranged 5,300 - 5,600 kJ (mean 5,400 kJ) or 79 - 83 kJ/ kg, 
suggesting a correlation with the high proportion of underweight 
individuals. There was not, however, a correlation between total 
energy intake and individual body weight. This result was 
considerably less than total energy intakes in other studies, with 
total energy intakes of 7,800 kJ and 9300 kJ recorded 
(Talemaitoga et al., 1989, Allman, 1989). These studies had 
similar dietary intake assessment methods and similar, yet 
smaller sample sizes. Talemaitoga et al (1989) was investigating 
nutrient intakes in home dialysis patients only, with no dietary 
restrictions recommended, which may have influenced the total 
energy intake. Allman (1990) identifies a misperception of 
haemodialysis patients in that dietary advice having focused on 
the restriction of food may contribute to poor intakes. Some 
patients claimed to decrease their food intakes because they have 
been rebuked about excess weight gain between dialysis. There 
seems to be confusion amongst patients between weight gain due 
to fluid overload and actual weight gain due to an increase in 
"dry" body weight (dry body weight is a clinical estimation of 
weight when normally hydrated) (Allman, 1990). 
There was no significant difference in total energy intake or 
body weight between the dialysis categories. 
5.2 Protein Intake 
Two of the primary nutrients targetted for intervention in 
the dietary management of renal disease are protein and 
phosphate. Available clinical data from different groups strongly 
suggest the progression of end stage renal disease in humans may 
be retarded or halted by treatment with a low protein diet 
supplemented with amino acids or keto acids (Barsotti et al, 1981, 
Alvestrand et al., 1983, Kluthet et al., 1971, Fouque et al., 1992). 
Since acute enhancement of glomerular filtration occurs after a 
protein meal, it is conceivable that hyperfiltration and further 
destruction of the renal parenchyma may be avoided by or 
delayed by the restriction of protein (Pullman et al., 1954, 
Bergstrom et al., 1985). 
Once haemodialysis has commenced, the protein restriction 
may be s l ight ly relaxed f rom the pre-d ia lys is diet 
recommendations to 1.0 to 1.2 grams of protein per kilogram of 
body weight (Kluthet et al., 1978, Ward et al., 1979, Allman, 1989, 
D.A.A. No 6 Clinical Handbook , 1990) . 
Eighty per cent of individuals consumed significantly less 
than the recommended 1.0 - 1.2 grams of protein per kilogram 
body weight. Intakes ranged from 26 - 101 g/day (0.38 - 1.5 
g/kg). The average protein intake of 54 grams (0.8 g/kg) was 
lower than a previous Australian study, where an intake of a 
sample of 50 hemodialysis patients was recorded as 1.2 g/kg body 
weight (Allman, 1990). A New Zealand study of home dialysis 
patients assessed the mean protein intake as 1.3 g/kg body 
weight (Talemaitoga et al., 1989), being higher than their 
counterparts in Germany (0.9 g/kg) (Schaeffer et al., 1975), Italy 
(1.23 g/kg) (Guarnieri et al., 1980), U.S.A. (l.Og/kg) (Thunberg et 
al., 1981, Wolfson et al., 1984). Another New Zealand study in 
1985, however, states an intake of 0.8 g/kg (Doube et al., 1985), 
suggesting that comparisons between countries should be treated 
with caution. The results can be used to compare the intake of the 
sample population to similar populations, showing that there was 
a low protein intake. 
It is recommended that haemodialysis patients have at least 
70% of protein intake from a high biological value source to 
ensure that the essential amino acid requirements are met 
(Zeman, 1991). Extra nitrogen is used by the body to synthesise 
the non-essential amino acids and thus reduces the amount of 
urea that must be excreted from the system. Twenty-seven per 
cent of the sample population consumed greater than the 
recommended, with the mean high biological value protein being 
60% of protein intake. There was no significant difference in high 
biological value protein consumption between the dialysis groups, 
and no correlation demonstrated between protein intake and high 
biological value intake. Uraemia causes some taste abberations. 
noticeably to red meats, making the high/low biological value 
ratio difficult to achieve (Krause et al., 1986). 
5.3 Iron Intake 
A correlation (r=0.69) was demonstrated between protein 
intake and iron intake. Individuals consuming a high protein 
intake generally had a high iron intake, as meat is a source of both 
protein and iron. The average iron intake was 7.8 grams, being 
significantly below the recommended 10 - 18 grams per day 
(Ward, 1991). It has been suggested that the recommended range 
may be set too high, as few individuals meet the dietary 
requirements (Krause et al., 1986). Talemaitoga et al (1989) state 
an average intake of 11.3 g iron. An adequate iron intake is 
important, with anaemia being common among haemodialysis 
patients. Gastrointestinal losses, losses in the dialysis procedure 
and a poor dietary intake may predispose individuals to iron 
deficency (Kinney et al., 1988). 
5.4 Zinc Intake 
The mean zinc intake was significantly below the standard 
intake. Zinc deficiency may be responsible for reduced taste 
acuity, loss of appetite and sexual dysfunction in uremic patients, 
often caused by protein restriction and losses in the dialysate 
(Walser, 1983, Birks, 1991, Weinsier et al., 1989). Reduced taste 
acuity may contribute to a poor oral intake common among 
haemodialysis patients. 
5.5 Vitamin Intake 
Deficiencies in water-soluble vitamins may be related to a 
poor food intake, altered metabolism and losses in dialysate. 
Supplementation practices of the actual vitamins and the dosage 
administered to patients differs widely among major renal units 
in Australia (Allman, 1989). Dosage close to the Recommended 
Daily Intakes (RDI) are suggested for thiamin, riboflavin and 
niacin, considering that many patients have lost part or all of the 
normal capacity to excrete potentially toxic levels of water-soluble 
vitamins (Allman, 1990, Birks, 1991, Weinsier et al., 1989). The 
intakes of the B vitamins analysed were all significantly below the 
RDI and thus the recommended intake for haemodialysis patients. 
5.6 Phosphate Intake 
The effect of the restriction of protein and phosphate has 
not been clearly separated, since dietary restriction of phosphate 
entails restriction of protein and vice versa. The lack of effect of 
treatment with a low phosphate diet on the progression of renal 
disease in some patients suggest that preservation of renal 
function may be mediated by the restriction of protein per se 
(Barrientos et al., 1982). 
Hyperphosphatemia and associated hyperparathyroidism 
may inflict further renal damage. Therefore, it is important to 
maintain serum phosphate levels at the lower end of the normal 
range, with an intake of 1000 - 1200 mg per day and using 
phosphate binders when dietary restriction is insufficient (D.A.A. 
No. 6 Clinical Handbook 1990). There is, however, a delicate 
balance. Too little dietary phosphate, which is indicative in a low 
protein diet, may predispose the renal patient to phosphate 
depletion and skeletal déminéralisation (Krause et al., 1986, 
Passmore et al., 1986) 
The mean intake of the sample of 805 mg/day (range 343 -
1296 mg) was significantly less than the recommended. No 
significant difference was demonstrated between the dialysis 
groups. 
5.7 Potassium Intake 
Renal tubular damage from chronic renal failure often 
impairs potassium filtration, leading to hyperkalaemia that can 
result in fatal arrythmias and possible cardiac arrest . 
Hyperkalaemia is most likely to occur if catabolism is present, 
with potassium being a bi-product of muscle breakdown, or with 
oliguria or acidosis (Shils et al., 1988, Zeman, 1991). 
In late renal failure, oliguria supervenes and potassium 
balance becomes precarious. Control is essential, since high serum 
levels cause arrythmias and possible cardiac arrest (Zeman, 1991). 
The recommendations for the haemodialysis patient is an intake 
of no greater than 60 mmoles or 1 mmol/kg Reference Body 
Weight per day (D.A.A. Handbook No 6, 1990, Calverley, 1992 -
pers. comm.). Talemaitoga et al (1989) reports a potassium intake 
of 65 mmoles per day in a sample home dialysis population. 
The sample population had a mean intake of 39 mmoles of 
potassium per day. This is a significant difference at the 5% 
confidence level to the recommended intake. No significant 
difference in intake was demonstrated between the three dialysis 
categories. The data for this study was also used in a concurrent 
study assessing seasonal variation in potassium intake. Patient 
knowledge of this investigation may have resulted in an 
exaggerated low intake, if the patients either subconsciously 
altered intake of potassium rich foods or misrecorded in the Food 
Diary. 
5.8 Fibre Intake 
Foods high in potassium content often have a high fibre 
content. Restrictions of potassium intake may suggest a low fibre 
diet. Constipation, Irritable Bowel Syndrome, diverticulitis, and 
colon cancer may be directly or indirectly caused by a low fibre 
intake (Shils et al., 1988). An ideal intake of 30 grams dietary 
fibre is recommended for both haemodialysis patients and the 
general population for the prevention of such disorders. 
The actual intake of dietary fibre in the sample population 
was less than half the recommended intake, and showed a 
significant difference at the 5% confidence level. While the 
genera l popu la t ion f inds it d i f f i cu l t reaching such a 
recommendation, the haemodialysis patient may find it more so, 
with the added problem of potassium content in high fibre foods. 
A correlation (r=0.77) was found between potassium and dietary 
fibre intake. Those individuals consuming a higher fibre diet 
generally had a higher consumption of potassium. 
5.9 Sodium Intake 
When glomerular filtration rate is reduced in chronic renal 
failure, filtration is impaired and reabsorption is fixed and unable 
to adapt to changes in sodium intake. Thus, patients may be 
unable to excrete the quantity of sodium ingested, and they may 
develop oedema, hypertension and congestive heart failure (Shils 
et al., 1988, Zeman, 1991). 
A sodium restriction of 70 - 100 mmoles per day is aimed at 
eliminating oedema if present, and normalising blood pressure 
and serum sodium levels (Kohlhardt, 1992). The sample 
population had a sodium intake within the recommended 
parameters, comparing favourably to a similar study where 
sodium intake was recorded at 114 mmoles per day (Talemaitoga 
et al., 1989). There was no significant difference demonstrated 
between the actual intake and the recommendations or between 
the intakes of the dialysis categories. An intake within this range 
ensures against dehydration, hypotension and further reduction of 
glomerular filtration rate. 
5 . 1 0 Saturated Fat Intake 
Haemodialysis patients have a high incidence of Type IV 
hyperlipoproteinemia with elevated serum triglyceride levels, a 
high serum high-density lipoprotein (HDL) cholesterol and 
elevated serum low-density lipoproteins (LDL) and very low-
density lipoproteins (VLDL) (Kinney et al., 1988). Such lipid 
fractions are suggestive of a high incidence of athersclerosis and 
cardiovascular disease in dialysis patients. 
Elevated serum triglyceride levels appear to be caused 
primarily by impaired clearance from the blood. In addition, the 
diet prescribed for renal failure restricting protein, potassium, 
sodium and water makes it difficult to provide sufficient energy 
without a large intake of simple sugars that may increase 
triglyceride production (Kinney et al., 1988). Fat is also often used 
to make up the energy deficit experienced with extensive dietary 
restrictions. Diets low in saturated fats have shown to reduce 
serum lipids and retard the progression of renal disease in early 
renal failure (Ward, 1990, Kohlhardt,1992). Though dietary 
modification to delay or prevent the adverse effects seems to be a 
logical procedure, planning is difficult. In addition, while 
saturated fat intake should ideally be restricted, it is not 
considered of prime importance in the renal diet in the Hunter 
region (Calverley, 1992 - pers. comm.). 
The sample population had an intake of 41% of total energy 
from saturated fat sources. This is well in excess of the 
recommended 10% advised for both the general population and 
dialysis patients. There was no significant difference in intake 
between the dialysis ctaegories. 
5.11 Dietary Adherence 
Adherence to dietary restrictions is but one important 
component in the care and well being of the end stage renal 
patient. Few chronic treatment plans are as complex and 
demanding as those prescribed for the dialysis patient. Given the 
potential consequences of non-compliance for patients with regard 
to morbidity and mortality, for families with regard to 
psychosocial stress, and for society with regard to health care 
costs, there is liitle doubt that the topic of adherence is an integral 
part of patient dialytic care (McKevitt et al., 1990). 
Dietary adherence is extremely difficult to measure, 
although there have been a number of studies on this issue. Not 
withstanding that the definition of compliance itself is unclear, the 
degree of compliance reported in patients with various medical 
conditions varies, in part, depending upon which measures of 
dietary compliance are used. Estimates of dietary adherence to 
restrictions in haemodiaysis patients by virtue of foods consumed 
have ranged from 28 to 70 per cent of that population (Haynes et 
al., 1979). 
What determines the adherence of the renal patient to 
dietary restrictions? Psychological, environmental and social 
factors all play a pivotal role. Attempts to link personality types 
with dietary adherence were unsuccessful by Porter (1969), as 
were demographic characteristics (Marston, 1970). Cummings et 
5 1 
al. (1982) has found some correlation with age, with older patients 
being better compliers. Patient attitude towards the disease and 
treatment, rather than factual knowledge have been shown to 
correlate best to the degree of adherence (Becker et al., 1975). 
The results of the study show that most patients did not 
have nutrient intakes within the recommended parameters. The 
recommendations are physiological ideals, yet we apply them to 
real people in the real world. Are our recommendations perhaps 
unrealistic? Are our expectations of patients unrealistic? 
The sample population had intakes significantly below the 
recommended intakes for the majority of nutrients investigated. 
With the message of restriction reinforced in the renal diet, could 
it be that it is perhaps too restrictive, or unnecessarily restrictive? 
In doing so, perhaps we have a more detrimental effect by 
contributing to the wasting and eventual malnourishment 
common among haemodialysis patients rather than the 
preservation of renal function? It is suggested that in the clincial 
setting, the main focus of dietetic counselling carry a positive 
message, with a balance between promoting food consumption in 
the context of dietary restrictions. 
Future research should attempt to investigate issues of 
compliance or adherence to recommendations, and target what 
influences the patient's capacity and motivation to adhere, and 
how best we can use such information in patient education. 
Chapter 6 
Conclusions and Recommendations 
Chapter 6 
C o n c l u s i o n 
In this study, the energy and nutrient intakes of a sample 
population on haemodailysis were compared to the recommended 
intakes. Protein, phosphate and potassium intakes were found to 
be significantly different at the 5% confidence interval. Sodium 
was the only nutrient consumed within the recommended level. 
Nutrients such as iron, zinc, and the B group vitamins were 
consumed below the recommended levels. The proportion of fat 
consumed as saturated fat was higher than recommended, while 
total energy intake was largely inadequate. 
There was no significant differences in nutrient intakes 
between the dialysis groups, suggesting that no one category was 
any more at risk. 
5 3 R e c o m m e n d a t i o n s 
Future researchers should take into consideration several 
recommendations for improvement. The sample size was a major 
limitation of the study. A larger number would have given a 
more representative sample. Information on demographic data 
such as height (to determine Body Mass Index), age, medication 
and length of time on dialysis would have proved useful. 
Evaluation of intakes of folate, vitamin C and pyridoxine 
would have provided a more extensive nutrient intake analysis. 
Serum levels of vitamins and minerals would have proved 
beneficial in determining vitamin status, considering the vitamin 
losses in the dialysis procedure and alterations in absorption of 
various nutrients. 
The identification of particular foods contributing to an 
elevated intake of a certain nutrient would have been useful in a 
clinical setting, and also pin pointing those that appeal to this 
population so that optimal menus and diet charts can be 
developed and implemented to ensure adequate nutritional intake 
among haemodialysis patients. 
Future directions for research should focus on issues of 
adherence, factors influencing the capacity and motivation of 
patients to comply and how best we can use such information in 
the clinical setting for a more effective nutrition education service. 
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Category Males (n=) Females (n=) 
Wansey L.C. 6 5 
Home 7 7 
Centre 3 9 
Total 16 21 
Appendix 2. Sex Distribution of Sample Haemodialysis Population. 
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OOHN HUNTER HOSPITAL 
DEPARTMENT OF NEPHROLOGY 
F ' O O D A N JO D R j n s r J K D J T A R Y 
You are invited to participate in this study by completing this food 
and drink diary. Your participation is voluntary and failure to 
participate will in no way affect your status in the Hospital or 
Centre. All details provided by you will be treated confidentially. 
Thank you for agreeing to participate in our study 
A food and drink diary is a daily record of everything you eat and 
drink over a period of three (3) days. It is important for us to know 
exactly the amount of food and drink you usually consume. People often 
change what they eat and drink as soon as they are asked to record it. 
Please make a conscious effort not to let this happen to you. We would 
like you to maintain your usual diet over a three (3) day period and 
accurately record the foods you eat and drink. 
The diary will record from your first meal on day one (1) to your last 
meal on day three (3). 
Please read the following steps on keeping a food and drink diary. 
MANY THANKS FOR YOUR CO-OPERATION 
HOW TO FILL IN YOUR DIARY 
* Use a blue of black pen when writing down everything you eat and drink 
* You will need to fill in all columns 
* Please start each day on a new page 
COLUMN I TYPE OF MFAI 
Everytime you have something to eat or drink, write down the meal 
eg. breakfast, or if it was a snack 
COLUMN 2 NAME AND FULL DESCRIPTION OF ALL FOOD AND DRINK 
For each food and drink use a new line. You may use more than 1 line 
to describe your food. 
Write down the type and name of foods and when possible, the brand 
name. eg. Arnotts milk arrowroot biscuit 
Tip Top white bread 
Lamb, loin chop 
Skin/whole nilk 
If the food was coated, write down if it was coated in flour, crumbed 
or batter. Write down if the fat was eaten or not eaten. Write down 
if the skin on the poultry was eaten of not eaten. If the dish is a 
mixture of several foods, name the dish, and all the separate 
ingredients you can see in it or know are there. Examples of food 
mixtures are stew, soup, coleslaw and mashed potato. 
For sandwiches and rolls, measure each ingredient as it is being made, 
if you can. If the sandwich is already prepared, name each ingredient 
and the number of sandwiches or rolls eaten (1 sandwich has 2 slices of 
bread). 
Remember to record foods added to other foods such as milk and sugar in 
tea and coffee, gravy, sauce or pickles on meat or in sandwiches, cream 
or icecream on dessert. Include alcoholic drinks. Flavourings such as 
icecream topping or Milo in milk drinks. Remember to write down all 
snacks and nibbles and foods eaten away from home. 
( A m p ^ e d : M d v i M ^ tiebutí ̂ u w ^ fw s o ^ w \ ( H \ á m , i W i 
COj-UMN 3 COOKING METHOD 




roasted or steamed 
Write down if the food was pre-soaked. If the food is cooked, measure 
it cooked, not raw. 
COLUMN 4 WHERE FOOD m PREPARED 
Was the food prepared at home, at a restaurant or a take-away outlet ? 
COLUMN 5 AMOUNT OF FOOD 
Record the amount eaten by size (spoons, cups, carton and circles) 
Do not weigh your food 
For a dish that is a mixture of several foods, write down the total 
amount of the mixed dish eaten. There is no need to record the amount 
of each separate ingredient for example: 1 cup fried rice. 
For meat and chicken, write down if the measurements taken are with the 
bone or without bone and with or without fat. 
If you do not eat all the food that is served out to you, write down 
how much of each food if left. 
There is no need to measure cores, peels or fish bones. 
Thank you for you participation. Please remember that it is very 
important that we know exactly the amount of food and drink you usually 
consume. These records will be treated as strictly confidential. 
THANK YOU FOR YOUR PARTICIPATION IN THIS STUDY 
WE HOPE THAT FUTURE RESULTS WILL BE OF BENEFIT TO YOU 
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OF STUDY DIALYSIS/NON DIAYSIS/WEEKEND ID NUMBER FOOD RECORD FOR DAY 
PLEASE WRITE IN BLUE OR BLACK PEN. REMEMBER TO RECORD EVERYTHING YOU EAT OR DRINK TODAY 
TYPE OF MEAJL FOOD OR DRINK ITEM OR 
CONTAINER 
COOKING METHOD WHERE FOOD WAS 
PREPARED 
AMOUNT OF FOOD 




FOOD RECORD FOR DAY OF STUDY DIALYSIS/NON DIAYS IS/WEEKEND ID JNUiyiiiiiiK 
xn PLEASE WRITE IN BLUE OR BLACK PEN. REMEMBER TO RECORD EVERYTHING YOU EAT OR DRINK TODAY 
TYPE OF MEAL FOOD OR DRINK ITEM OR 
CONTAINER 
COOKING METHOD WHERE FOOD WAS 
PREPARED 
AMOUNT OF FOOD 





FOOD RECORD FOR DAY. OF STUDY DIALYSIS/NON DIAYSIS/WEEKEND ID NUMBER 
vo PLEASE WRITE IN BLUE OR BLACK PEN. REMEMBER TO RECORD EVERYTHING YOU EAT OR DRINK TODAY 
TYPE OF MEAL FOOD OR DRINK ITEM OR 
CONTAINER 
COOKING METHOD WHERE FOOD WAS 
PREPARED 
AMOUNT OF FOOD 
SIZE AND NUMBER 
AMOUNT OF 
FOOD LEFT 
HOW TO MEASURE YOUR FOOD 
• If your food is cooked, measure il cooked, not raw. 
• Measure the food atter It is served. 
• if you do not eat all the food you first served out, measure and write down 
how much of each food is left. 
• There is no need to measure left over cores, peel or fish bones. 
Measure your food using: 
Cups and spoons 
• Use cups and spoons to measure liquid foods and foods like 
cereal, sugar, stews, rice and vegetables. 
• Measure as level, never heaped. 
Circles 
• Use the circles to measure foods which are shaped like a ball for example 
apples, tomatoes, oranges, round bread rolls. 
• Put one edge of the food on the black dot. look down from the top and 
choose which is the closest fit. 
• Round flat foods like hamburgers and biscuits may also be measured using 
the circles or by measuring how wide it is across with your ruler. You also 
need to measure the thickness of these foods with your mler. 
Ruler 
Where cups, spoons and circles won t work, use a ruler. ^^ . ^ . 
Examples oi foods lo measure iK.s way are p.eces of meal. cake, bread. 
. For round, flat loods. measure how w»de it is across and Ihe thickness. 
. For foods of other shapes, measure how long by how wide by how thick it 
. Draw a small picture lo help you describe the shape ol food and show where 
the food was measured. 
. Use your ojler to measure your food. If you do not have it with you 
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One medium glass 
One sl ice of cake 
One mediura cup 
Appendix 4 
FOOD AND DRINK DIARY QUESTIONNAIRE 
I.DWMBER: 
The following questions are concerned with the way you prepare or cook your food and some of your food habits. Your answers will help us to make the analysis of your diet more accurate. If you don't usually cook or prepare your own food, please feel free to ask the person who does it for you. 
Remember - circle the number closest to the amount you have. 
1. When you drink milk or add it to tea/coffee etc., do you mostly use: Whole milk 1 Ute-White 2 Shape 3 Skim 4 
Ifother,pleasespecify 
2. Do you have milk: Yes No Don't Drink It In your tea? 1 2 3 In your coffee? 1 2 3 In coffee substitute? 1 2 3 
3. How many teaspoons of sugar do you usually have in each 
cup of: Tea 0 1 2 3 4 5 6 Coffee 0 1 2 3 4 5 6 Coffee Substitute 0 1 2 3 4 5 6 Cocoa/Chocolate 0 1 2 3 4 5 6 
4. Do you make your cocoa or chocolate with: 
Mostiy milk 1 Mostly water 2 About half and half 3 DonQLdrink 4 
5. If you often or always have breakfast cereal, please answer the next to questions (If not, go to question 4). a) How many cups of milk do you usually add to breakfast cereal? 0 0.5 1 1.5 2 2.5 3 cups 
(circle the number closest to the amount you have) 
b)How many teaspoons of sugar do you usually add to 
breakfast cereal? 
(1 dessertspoon = 2 teaspoons) 
0 1 2 3 4 5 6 
(circle the number closest to the amount you have) 
6. When you eat meat with fat on it, do you eat 
All of the fat 1 
Most of the fat 2 
About half of the fat 3 
Little or none of the fat 4 
1 do not eat meat 5 
7. Do you ( or the peron who cooks for you) add salt to the 




8. If salt was added to the cooking water when boiling foods, is 
the water 
Lightly salted 1 
Medium salted 2 
Heavily salted 3 
Salting is highly varied 4 
9. How often do you add salt to your meals after they are 
cooked (i.e. at the table)? 
Rarely or never 1 
Only after tasting food 2 
Always or nearly always 3 
10. Which of the following do you usually spread on crackers or 
bread? 
Butter 1 
Cooking/table marg (not poly) 2 
Polyunsaturated margarine 3 
Nothing 4 
Ifother,pleasespecify 




Half wholemeal, half white 4 
Half brown, half white 5 
Half brown, half wholemeal 6 
I don't eat bread 7 
If other type, please specify 
12. When your meat is fried or roasted, which do you (or the 
person who usually cooks your food) use most often? 
Butter 1 
Dripping (beef or lamb) 2 
Lard 3 
Cooking/tablemargarine 4 
Polyunsaturated margarine 5 
Vegetable oils 6 
Cooked in own j uices 7 
I never fry or roast meat 8 
Ifother,pleasespecify. 
13. When frying or roasting vegetables, which do you (or the 
person who cooks your food) use most often? 
Butter 1 
Dripping ( beef or lamb) 2 
Lard 3 
Cooking/tablemargarine 4 
Polyunsaturated margarine 5 
Vegetable oils 6 
I never fry or roast veges 7 
Ifother,pleasespecify. 
Thank you very much for assisting in our research. 
We hope the results will be of benefit to you. 
Appendix 5 
GUIDELINES FOR INTERVIEWERS 
GUIDELINES FOR INTERVIEWERS 
(verbal presentation) 
1. Introduction. 
2. Explanation of: 
i) research project. 
ii) relevance to patient. 
ill) results to be presented in the Dialysis 
Seminar 1993. 
iv) entirely voluntary. 
3. Description of Food Diary: 
i) non-judgemental. 
ii) importance of '^usual" intake. 
iii) detailed as possible description of foods. 
iv) give an example of breakfast 
ie. toast» butter, jam, egg,, cereal, coffee. 
v) fill in sample day on spare diary sheet. 
vi) explain that it is to be entered into 
computer, therefore detail is needed. 
Any questions? 
4. Explain two phenomena often occurring when people are 
asked to record their intake: 
i) Participants consciously or unconsciously change 
their eating habits during the recording period or 
ii) Participants do not record the foods consumed they 
think they should not have consumed (eg. chocolate). 
Stress that it is a non-judgemental exercise, and very 
important for a "usual" intake. 
Any questions? 
5. Describe the Food Diary Questionnaire: 
- purpose is to clarify points on the Diary when 
they are later entered into the computer. 
6. Complete questionnaire with patient, if possible. 
Any questions? 
7. Obtain details for Patient Profile Card 
eg. "dry" weight, dialysis details, medications. 
8. Describe urine and faeces sample: 
Urine: If sufficient urine output, provide patient with a 
24-hour urine collection bottle, and detail start and finish times 
(ie. begin after the first void on Day 1 and finish after the first 
void on Day 2). If urine output is less than 100ml, provide urine 
sample jar and ask patient to note the time of void and the time of 
the previous void. If no urine output, they are exempt from this 
part of the study. 
Faecal: Provide patient with faecal sample jar and a 
sheet detailing suggested procedures. 
Any questions? 
9. Provide contact phone number. 
10. Thank patient for their co-operation. 
Ref: Gosper, J., Barth, R., Campbell, L. 1989. Practice guidelines: 
satisfactory food records - a new method of instruction. 
Australian Tnnrnal Nutrition & Dietetics. 46: 2; 46-47. 
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Appendix 6.1 Comparison of Protein Intakes Between Dialysis Categories. 
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Appendix 6.2 Comparison of Phosphorus Intakes Between Dialysis Categories. 
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WANSEY CENTRE HOME 
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Appendix 6.4 Comparison of Potassium Intakes Between Dialysis Categories. 
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Appendix 6.5 Comparison of Percentage Saturated Fat Intakes 













PERCENTAGE HIGH BIOLOGICAL VALUE 
PROTEIN BY DIALYSIS CATEGORY 
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Appendix 6.6 Comparison of Percentage High Biological Value Protein 
Between Dialysis Categories. 
MEAN IRON INTAKE BY DIALYSIS CATEGORY 
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Appendix 6.7 Comparison of Iron Inakes Bevvteen Dialysis Categories. 
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Appendix 6.9 Comparison of Zinc Intakes Between Dialysis Categories. 
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Appendix 6.10 Comparison of Thiamin Intakes Between Dialysis Categories. 
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Appendix 6.11 Comparison of Riboflavin Intakes Between Dialysis Categories. 
MEAN NIACIN INTAKE BY DIALYSIS CATEGORY 
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Appendix 6.12 Comparison of Niacin Intakes Between Dialysis Categories. 
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Appendix 6.13 Comparison of Total Energy Intakes Between Dialysis Categories, 

